首页> 外文OA文献 >Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis
【2h】

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis

机译:足细胞足突消失作为局灶节段性肾小球硬化的诊断工具

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Podocyte foot process effacement is characteristic of proteinuric renal diseases. In minimal change nephrotic syndrome (MCNS) foot processes are diffusely effaced whereas the extent of effacement varies in focal segmental glomerulosclerosis (FSGS). Here we measured foot process effacement in FSGS and compared it to that in MCNS and in normal kidneys. A clinical diagnosis was used to differentiate idiopathic FSGS from secondary FSGS. Median foot process width, determined morphometrically by electron microscopy, was 3236 nm in 17 patients with idiopathic FSGS, 1098 nm in 7 patients with secondary FSGS, and 1725 nm in 15 patients with MCNS, as compared to 562 nm in 12 control patients. Multivariate analysis showed that foot process width did not correlate with proteinuria or serum albumin levels but was significantly associated as an independent factor with the type of disease. Foot process width over 1500 nm differentiated idiopathic from secondary FSGS with high sensitivity and specificity. Our results show that quantitative analysis of foot processes may offer a potential tool to distinguish idiopathic from secondary FSGS
机译:足细胞足突消失是蛋白尿性肾脏疾病的特征。在最小变化中,肾病综合征(MCNS)的脚部散在消失,而局灶性节段性肾小球硬化(FSGS)的覆盖程度却有所不同。在这里,我们测量了FSGS中的足突,并将其与MCNS和正常肾脏中的足突相比较。临床诊断用于区分特发性FSGS和继发性FSGS。用电子显微镜术形态学测定的足突中位宽度在17例特发性FSGS患者中为3236 nm,在7例继发性FSGS患者中为1098 nm,在15例MCNS患者中为1725 nm,而在12例对照患者中为562 nm。多变量分析表明,足突宽度与蛋白尿或血清白蛋白水平不相关,但与疾病的类型密切相关。 1500 nm以上的足突宽度可将特发性与继发性FSGS区别开来,具有很高的灵敏度和特异性。我们的结果表明,足部过程的定量分析可能为区分特发性和继发性FSGS提供潜在的工具

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号